Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enable Innovations
- Ownership
- Private
- Development stage
- Other
01
Overview
Enable Innovations is an Italian CDMO specializing in the development, aseptic production, and packaging of sterile liquid products—primarily eye drops and nasal sprays—classified as substance-based medical devices. The company holds ISO 13485:2021 certification and has obtained CE marking under MDR for its eye drop line. It offers both contract manufacturing services and ready-to-market certified products.
- Therapeutic areas
- PulmonologyOphthalmologyOther
- Modalities
- Device
- Industry
- Contract Manufacturing Organization
02
Partnerships
No major pharmaceutical or biotech partnerships specifically named; collaborates with external laboratories for development activities.
Beyond the preview
Go deeper on Enable Innovations.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Enable Innovations.